Following Ebisu and Ginza, the brand pairs Korea-inspired skin care with laser hair removal in a space of more than 660 square meters
IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that NEO Skin Clinic Nagoya will open on Saturday, August 22, 2026, in the Sakae area of Naka Ward, Nagoya. The clinic is the third location under NEO Skin Clinic, an aesthetic dermatology brand built on the concept of “Accessible Trend Beauty,” which aims to bring the skin care approaches widely discussed in South Korea within closer reach. Spanning more than 660 square meters, the Nagoya clinic offers laser hair removal alongside the skin treatments at the core of the brand.
In aesthetic healthcare, and in aesthetic dermatology in particular, new devices and pharmaceuticals continue to reach the market at a rapid pace. NEO Skin Clinic offers more than 50 treatments using the latest devices from Japan and South Korea, and updates its treatment lineup as trends and technologies evolve. The brand is led by Ayaka Nishikawa, M.D., Group Head of Dermatology at Shonan Beauty Clinic. Nariaki Miyata, M.D., who has built a long record of practice in aesthetic dermatology in Japan, and Seongjae Youn, M.D., Chief Director of the South Korean aesthetic dermatology group Leaders Dermatology Clinic, serve as technical advisors. Drawing on their respective areas of expertise, the clinic follows treatment protocols informed by clinical knowledge from both countries.
NEO Skin Clinic Nagoya is a two-minute walk from Hisaya-odori Station on the Nagoya Municipal Subway and sits directly opposite an exit of the Sakae underground mall. The interior is finished in beige and greige, with arch motifs and indirect lighting that combine a refined, luxurious feel with a calm atmosphere. Following a complimentary skin analysis and consultation using the VISIA skin analysis system, physicians propose a skin treatment plan tailored to each customer’s skin condition and preferences. The clinic’s scale also allows for expanded laser hair removal capacity, making appointments easier to secure and treatment courses easier to continue.
To mark the opening, the clinic will hold an opening campaign from Saturday, August 22 through Saturday, November 21, 2026. Details of eligible treatments and pricing are available on the clinic’s official website at https://www.sbc-neoskinclinic.jp/campaign-nagoya/
Note: Laser hair removal and skin treatments are self-pay care and are not covered by Japan’s public health insurance. Treatment details, costs, the number of sessions required, and principal risks and side effects are explained by the physician at the time of consultation.
SBC Medical is diversifying its business to meet increasingly varied customer needs. Its multi-brand strategy is one pillar of that effort, and NEO Skin Clinic is central to it. The Company will continue to extend its reach beyond major metropolitan centers, supporting customers in living healthy lives on their own terms.
Clinic Overview
Name: NEO Skin Clinic Nagoya
Opening Date: Saturday, August 22, 2026
Location: Tatenomachi Building 3F, 3-6-15 Nishiki, Naka-ku, Nagoya, Aichi 460-0003, Japan
Access: 2-minute walk from Hisaya-odori Station (Subway Meijo and Sakura-dori Lines); 2-minute walk from Sakaemachi Station (Meitetsu Seto Line); 3-minute walk from Sakae Station (Subway Higashiyama and Meijo Lines), directly opposite Exit 8A of the Sakae underground mall (Central Park)
Departments: Aesthetic dermatology
Business Hours: 10:00 to 19:00
Regularly Closed: Mondays and Thursdays
Telephone: 0120-237-917 (Toll-free within Japan)
Official Website: https://www.sbc-neoskinclinic.jp/
About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp